. Author manuscript; available in PMC: 2023 Feb 1.

Published in final edited form as: Int J STD AIDS. 2021 Nov 2;33(2):144–155. doi: 10.1177/09564624211050335

Table 4.

Smoking, gender, age, waist circumference, HIV status, cocaine use, and biomarkers predicting plaque (N = 506).

Variable	B	SE	OR	95% CI	p	FDR-corrected p
(Intercept)	−8.02	1.25			<0.001	<0.001
Smoking (ref = yes)	−0.3	0.28	0.74	−0.84, 0.24	0.281	0.743
Gender (ref = women)	0.08	0.26	1.08	−0.42, 0.58	0.756	0.881
Age	0.16	0.02	1.17	0.12, 0.19	<0.001	<0.001
Waist circumference	0.01	0.01	1.01	−0.01, 0.03	0.391	0.784
HIV status (ref = HIV positive)	0.14	0.46	1.15	−0.76, 1.03	0.761	0.881
Cocaine use (ref = cocaine user)	−0.14	0.45	0.87	−1.01, 0.74	0.761	0.881
HIV status x cocaine use	0.13	0.56	1.13	−0.96, 1.22	0.820	0.881
IL-1α (pg/mL)^a	0.23	0.24	1.25	−0.26, 0.72	0.357	0.784
IL-6 (pg/mL)^a	−0.24	0.29	0.79	−0.82, 0.35	0.424	0.784
TNF-α (pg/mL)^a	−0.15	0.23	0.86	−0.61, 0.31	0.518	0.871
VEGF (pg/mL)^a	−0.02	0.12	0.98	−0.25, 0.21	0.893	0.918
LPS (pg/mL)^a	−0.06	0.17	0.94	−0.39, 0.27	0.727	0.881
sCD163 (ng/mL)^a	−0.15	0.15	0.86	−0.44, 0.15	0.326	0.784
sCD14 (ng/mL)^a	−0.04	0.15	0.96	−0.33, 0.25	0.801	0.881
CRP (mg/L)^a	−0.03	0.15	0.97	−0.32, 0.26	0.833	0.881
CD309⁺CD34 (%)⁺^a	0.19	0.16	1.21	−0.12, 0.5	0.220	0.663
CD309⁺CD133 (%)⁺^a	0.05	0.17	1.05	−0.29, 0.38	0.781	0.881

FDR: false discovery rate correction for multiple comparisons; SE: standard error; OR: odds ratio; CI: confidence interval; IL-6: interleukin-6; TNF-α: tumor necrosis factor; VEGF: vascular endothelial growth factor; LPS: Lipopolysaccharide; CRP: C-reactive protein.

Standardized using a z-score transformation.